CASE REPORT
Cryptococcal meningitis in a patient with SLE as a complication of chronic steroid therapy
More details
Hide details
1
Collegium Medicum, Uniwersytet Rzeszowski, Polska
2
Zakład Reumatologii Collegium Medicum, Uniwersytet Rzeszowski, Polska
Corresponding author
Natalia Guzik
Collegium Medicum, Uniwersytet Rzeszowski, Kopisto 2a, 35-315, Rzeszów, Polska
KEYWORDS
TOPICS
ABSTRACT
This article presents a case report of a 26-year-old female patient with a 13-year history of Systemic Lupus
Erythematosus (SLE), who was admitted to the hospital with severe headaches, low-grade fever, diplopia, and arthritis.
These symptoms, although partially overlapping with an SLE flare, raised suspicion of an infectious complication or
Neuropsychiatric SLE (NPSLE). A neurological examination revealed significant focal deficits. Features of left abducens nerve (CN VI) palsy, a flattened nasolabial fold, and ataxia of the left lower limb were observed. Based on the clinical image, which combined systemic symptoms (fever, headache) with
focal neurological deficits (CN VI palsy, ataxia), a preliminary suspicion of meningitis (ZOMR) and/or encephalitis was raised. Following necessary diagnostic tests, including cerebrospinal fluid (CSF) analysis, the definite diagnosis was established: Cryptococcal Meningitis. This serious, rare fungal infection,
caused by Cryptococcus neoformans, is particularly dangerous for immunocompromised patients, including those treated
with immunosuppressants for SLE. This case has significant clinical implications. It suggests that in Lupus patients
presenting with symptoms indicative of central nervous system involvement, opportunistic infections must always be considered, even if the initial suspicion leans toward SLEassociated aseptic meningitis. The case underscores that the differential diagnosis must be broad, encompassing rare
pathogens, especially when neurological findings, though perhaps ambiguous for typical meningitis, clearly indicate underlying pathology.
REFERENCES (36)
1.
Didi P, Barliana Melisa I, Hamijoyo L. Dosage and Duration of Methylprednisolone Therapy Affect the Occurrence of Cushing Habitus in Patients with Systemic Lupus Erythematosus. J Pharm Bioall Sci. 2019;11: 628–34.
https://doi.org/10.4103/jpbs.j....
4.
Stojan G, Petri M. The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years? Curr Treatm Opt Rheumatol. 2017;3:164–172.
https://doi.org/10.1007/s40674....
6.
Molooghi K, Sheybani F, Naderi H, et al. Central Nervous System infections in patients with systemic lupus erythematosus: a systemic review and meta-analysis. Lupus Sci Med. 2022;9:1–10.
https://doi.org/10.1136/lupus-....
7.
Jiang S, Lei TC, Xu SZ. Successful Treatment of cryptococcal meningitidis with amphotericin B in a patient with systematic lupus erythematosus. West Indian Med J. 2016;65:222–225.
https://doi.org/10.7727/wimj.2....
8.
Arnaud L, Tektonidou Maria G. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology (Oxford). 2020;59:29–38.
https://doi.org/10.1093/rheuma....
9.
Emamikia S, Gentline C, Chatzidionysiou K, et al. Relationship between glucocorticoid dose and adverse events in systemic lupus erythematosus: data from a randomized clinical trial. Scand J Rheumatol. 2017;47:131–140.
https://doi.org/10.1080/030097....
10.
Cohen J, Pinching A, Rees A, Peters D. Infection and immunosuppression. A study of the infective complications of 75 patients with immunologically-mediated disease. Q J Med. 1982;51(201):1–15.
https://doi.org/10.1177/014107....
11.
Wu Q, Liu Y, Wang W, et al. Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: A systematic review and meta-analysis. Front Immunol. 2022;13:938406.
https://doi.org/10.3389/fimmu.....
12.
Pego-Reigosa J, Nicholson L, Pooley N, et al. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology. 2021;60:60–72.
https://doi.org/10.1093/rheuma....
13.
Battaglia M, Garrett-Sinha L. Bacterial infections in lupus: Roles in promoting immune activation and in pathogenesis of the disease. J Transl Autoimmun. 2021;4:1–13.
https://doi.org/10.1016/j.jtau....
14.
Horta-Baas G, Guerrero-Soto O, Barile-Fabris B. Central Nervous System Infection by Listeria monocytogenes in Patients With Systemic Lupus Erythematosus: Analysis of 26 Cases, Including the Report of a New Case. Reumatol Clin. 2013;9:340–347.
https://doi.org/10.1016/j.reum....
15.
Rao M, Mikdashi J. A Framework to Overcome Challenges in the Management of Infections in Patients with Systemic Lupus Erythematosus. Open Access Rheumatol. 2023;15:125–137.
https://doi.org/10.2147/oarrr.....
16.
Hui Min Charlotte Choo, Wen Qi Cher1, Yu Heng Kwanand Warren Weng Seng Fong. Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review. Adv Rheumatol. 2019;59:12.
https://doi.org/10.1186/s42358....
17.
Sebastiani GD, Iuliano A, Canofari A, Bracci M. Cytomegalovirus infection in Systemic Lupus Erythematosus: report of four cases challenging the management of the disease, and literature review. Lupus. 2019;1–6.
https://doi.org/10.1177/096120....
18.
Sciascia S, Bertolaccini M.L, Baldovino S, et al. Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. Autoimmun Rev. 2013;13.
https://doi.org/10.1016/j.autr....
19.
The American college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;44:599–608.
https://doi.org/10.1002/1529-0....
20.
Hanly JG, Urowitz MB, Su L, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2010;69:529–35.
https://doi.org/10.1136/ard.20....
21.
McGlassonS, Wiseman S, Wardlaw J, et al. Neurological Disease in Lupus: Toward a Personalized Medicine Approach. Front Immunol. 2018; 9.
https://doi.org/10.3389/fimmu.....
22.
Heba Ezzat Hashem, Zakaria Hamza Ibrahim. Atypical Presentation of Pediatric Systemic Lupus Erythematosus Complicated by Cryptococcal Meningitis Case Rep Med. 2021;1–10.
https://doi.org/10.1155/2021/6....
23.
Chin-Fang Su, Chien-Chih Lai, Tzu-Hao L, et al. Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study. Ther Adv Musculoskelet Dis. 2021;13:1–11.
https://doi.org/10.1177/175972....
24.
Lao M, Wang X, Ding M, et al. Invasive fungal disease in patients with systemic lupus erythematosus from Southern China: a retrospective study. Lupus. 2019;28:77–85.
https://doi.org/10.1177/096120....
25.
Frodlund M, Jonsen A, Remkus L, et al. Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality—a national cohort study. Rheumatology. 2024;63:1104–1112.
https://doi.org/10.1093/rheuma....
26.
Al Mahmeed N, El Nekidy WS, Langah R, Nusair AR. Meningitidis as the initial manifestation of systemic lupus erythematosus. IDCases. 2020;21:1–3.
https://doi.org/10.1016/j.idcr....
27.
Ngan N, Flower B, Day J. Treatment of Cryptococcal Meningitidis: How Have we got here and where are we going? Drugs. 2022;82:1237–1249.
https://doi.org/10.1007/s40265....
28.
Wang F, WangYu, He J, et al. Clinical Characteristics and Risk Factors for Mortality in Cryptococcal Meningitis: Evidence From a Cohort Study. Front Neurol. 2022;13:779435–442.
https://doi.org/10.3389/fneur.....
29.
Vela-Duarte D, Nyberg E, Sillau S, et al. Lacunar Stroke in Cryptococcal Meningitis: Clinical and Radiographic Characteristics. J Stroke Cerebrovasc Dis. 2019;28(6):1767–1772.
https://doi.org/10.1016/j.jstr....
30.
Chang C, Harrison T, Bicanic T, et al. Global guideline for the diagnosis and management of cryptococcosis. Lancet Infect Dis. 2024;23:731–734.
https://doi.org/10.1016/s1473-....
31.
Liang L, Liang Z, She D, Chen L. A case-control study of human immunodeficiency virus-negative patients with cryptococcemia and cryptococcal meningitis in a Chinese tertiary care hospital during 10 years. J Int Med Res. 2021;49:1–11.
https://doi.org/10.1177/030006....
32.
Fisher K, Montrief T, Ramzy M, et al. Cryptococcal meningitidis: a review for emergency clinicans. Intern Emerg Med. 2021;16:1031–1042.
https://doi.org/10.1007/s11739....
33.
Baizabal-Carvallo J, Delgadillo-Márquez G, Estañol B, García-Ramos G. Clinical Characteristics and Outcomes of the Meningitides in Systemic Lupus Erythematosus. Eur Neurol. 2008;8:143–148.
https://doi.org/10.1159/000186....
35.
Fisher Kunzler A, Tsokos G. Infections in Patients with Systemic Lupus Erythematosus: The Contribution of Primary Immune Defects Versus Treatment-Induced Immunosuppression. Eur J Rheumatol. 2023;10(4):148–158.
https://doi.org/10.5152/eurjrh....
36.
Jing He, Zhanguo Li. Dilemma of immunosuppression and infection risk in systemic lupus erythematosus, Rheumatol. 2023;62:22–29.